DAPT(Dual Antiplatelet Therapy)
5
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
OCT-based DAPT Cessation in HBR Patients
Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient
Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT（Dual Antiplatelet Therapy ） Within 6 Weeks vs After 6 Weeks Post-PCI（Percutaneous Coronary Intervention）: A Prospective Observational Cohort Study
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial